Operating Expenses Summary of PolyNovo Limited

PolyNovo Limited's latest annual operating expenses in 2024 was 34.92 Million AUD , up 36.86% from previous year.
PolyNovo Limited's latest quarterly operating expenses in 2024 FY was 34.92 Million AUD , up 36.86% from previous quarter.
PolyNovo Limited reported a annual operating expenses of 25.51 Million AUD in annual operating expenses 2023, up 54.79% from previous year.
PolyNovo Limited reported a annual operating expenses of 16.48 Million AUD in annual operating expenses 2022, up 50.23% from previous year.
PolyNovo Limited reported a quarterly operating expenses of 16.76 Million AUD for 2024 Q2, down 0.0% from previous quarter.
PolyNovo Limited reported a quarterly operating expenses of 34.92 Million AUD for 2024 FY, up 36.86% from previous quarter.

Annual Operating Expenses Chart of PolyNovo Limited (2024 - 1999)

Historical Annual Operating Expenses of PolyNovo Limited (2024 - 1999)

Year	Operating Expenses	Operating Expenses Growth
2024	34.92 Million AUD	36.86%
2023	25.51 Million AUD	54.79%
2022	16.48 Million AUD	50.23%
2021	10.97 Million AUD	19.95%
2020	9.14 Million AUD	-29.76%
2019	13.02 Million AUD	55.72%
2018	8.36 Million AUD	13.83%
2017	7.34 Million AUD	50.86%
2016	4.87 Million AUD	264.67%
2015	1.33 Million AUD	-56.27%
2014	3.05 Million AUD	-10.74%
2013	3.42 Million AUD	-20.65%
2012	4.31 Million AUD	1.2%
2011	4.26 Million AUD	27.15%
2010	3.35 Million AUD	12.69%
2009	2.97 Million AUD	-44.93%
2008	5.4 Million AUD	-61.34%
2007	13.96 Million AUD	10.99%
2006	12.58 Million AUD	8.88%
2005	11.55 Million AUD	-6.51%
2004	12.36 Million AUD	33.76%
2003	9.24 Million AUD	128.76%
2002	4.04 Million AUD	40300.0%
2001	10 Thousand AUD	100.28%
2000	-3.55 Million AUD	-118.08%
1999	-1.62 Million AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q4	18.45 Million AUD	0.0%
2024 Q2	16.76 Million AUD	0.0%
2024 FY	34.92 Million AUD	36.86%
2023 Q4	12.15 Million AUD	0.0%
2023 FY	25.51 Million AUD	54.79%
2023 Q2	12.99 Million AUD	0.0%
2022 Q4	9.07 Million AUD	0.0%
2022 Q2	7.31 Million AUD	0.0%
2022 FY	16.48 Million AUD	50.23%
2021 FY	10.97 Million AUD	19.95%
2021 Q2	4.4 Million AUD	0.0%
2021 Q4	6.68 Million AUD	0.0%
2020 FY	9.14 Million AUD	-29.76%
2020 Q2	4.46 Million AUD	0.0%
2020 Q4	4.15 Million AUD	0.0%
2019 Q2	5.54 Million AUD	0.0%
2019 Q4	4.06 Million AUD	0.0%
2019 FY	13.02 Million AUD	55.72%
2018 FY	8.36 Million AUD	13.83%
2018 Q2	4.18 Million AUD	0.0%
2018 Q4	4.17 Million AUD	0.0%
2017 Q2	3.16 Million AUD	0.0%
2017 FY	7.34 Million AUD	50.86%
2017 Q4	4.18 Million AUD	0.0%
2016 Q4	2.21 Million AUD	0.0%
2016 Q2	2.66 Million AUD	0.0%
2016 FY	4.87 Million AUD	264.67%
2015 FY	1.33 Million AUD	-56.27%
2015 Q4	262.87 Thousand AUD	0.0%
2015 Q2	1.59 Million AUD	0.0%
2014 FY	3.05 Million AUD	-10.74%
2014 Q4	1.62 Million AUD	0.0%
2014 Q2	1.42 Million AUD	0.0%
2013 Q3	166.89 Thousand AUD	-87.39%
2013 Q4	1.25 Million AUD	649.47%
2013 FY	3.42 Million AUD	-20.65%
2013 Q2	1.32 Million AUD	655.42%
2013 Q1	175.24 Thousand AUD	0.0%
2012 Q2	175.24 Thousand AUD	-39.91%
2012 Q1	291.62 Thousand AUD	0.0%
2012 Q4	175.24 Thousand AUD	0.0%
2012 Q3	175.24 Thousand AUD	0.0%
2012 FY	4.31 Million AUD	1.2%
2011 Q4	291.62 Thousand AUD	0.0%
2011 Q1	167.62 Thousand AUD	0.0%
2011 FY	4.26 Million AUD	27.15%
2011 Q3	291.62 Thousand AUD	0.0%
2011 Q2	291.62 Thousand AUD	73.98%
2010 Q2	167.62 Thousand AUD	-15.04%
2010 FY	3.35 Million AUD	12.69%
2010 Q3	167.62 Thousand AUD	0.0%
2010 Q4	167.62 Thousand AUD	0.0%
2010 Q1	197.28 Thousand AUD	0.0%
2009 FY	2.97 Million AUD	-44.93%
2009 Q3	197.28 Thousand AUD	0.0%
2009 Q1	533.08 Thousand AUD	0.0%
2009 Q4	197.28 Thousand AUD	0.0%
2009 Q2	197.28 Thousand AUD	-62.99%
2008 Q1	2.24 Million AUD	0.0%
2008 FY	5.4 Million AUD	-61.34%
2008 Q4	533.08 Thousand AUD	0.0%
2008 Q3	533.08 Thousand AUD	0.0%
2008 Q2	533.08 Thousand AUD	-76.3%
2007 Q2	2.24 Million AUD	6.07%
2007 Q4	2.24 Million AUD	0.0%
2007 Q3	2.24 Million AUD	0.0%
2007 FY	13.96 Million AUD	10.99%
2007 Q1	2.12 Million AUD	0.0%
2006 Q3	2.12 Million AUD	0.0%
2006 Q4	2.12 Million AUD	0.0%
2006 FY	12.58 Million AUD	8.88%
2006 Q2	2.12 Million AUD	173.38%
2006 Q1	-2.88 Million AUD	0.0%
2005 Q1	246.38 Thousand AUD	0.0%
2005 Q4	-2.88 Million AUD	0.0%
2005 Q3	-2.88 Million AUD	0.0%
2005 Q2	-2.88 Million AUD	-1272.64%
2005 FY	11.55 Million AUD	-6.51%
2004 Q1	-2.28 Million AUD	0.0%
2004 FY	12.36 Million AUD	33.76%
2004 Q2	246.38 Thousand AUD	110.77%
2004 Q4	246.38 Thousand AUD	0.0%
2004 Q3	246.38 Thousand AUD	0.0%
2003 Q3	-2.28 Million AUD	0.0%
2003 Q4	-2.28 Million AUD	0.0%
2003 Q2	-2.28 Million AUD	-21733.98%
2003 Q1	10.57 Thousand AUD	0.0%
2003 FY	9.24 Million AUD	128.76%
2002 Q3	10.57 Thousand AUD	0.0%
2002 Q4	10.57 Thousand AUD	0.0%
2002 Q2	10.57 Thousand AUD	522.92%
2002 FY	4.04 Million AUD	40300.0%
2002 Q1	-2500.00 AUD	0.0%
2001 Q3	-2500.00 AUD	0.0%
2001 FY	10 Thousand AUD	100.28%
2001 Q4	-2500.00 AUD	0.0%
2001 Q2	-2500.00 AUD	99.86%
2001 Q1	-1.77 Million AUD	0.0%
2000 FY	-3.55 Million AUD	-118.08%
2000 Q1	-815.96 Thousand AUD	0.0%
2000 Q2	-1.77 Million AUD	-117.97%
2000 Q3	-1.77 Million AUD	0.0%
2000 Q4	-1.77 Million AUD	0.0%
1999 Q2	-815.96 Thousand AUD	0.0%
1999 Q3	-815.96 Thousand AUD	0.0%
1999 Q4	-815.96 Thousand AUD	0.0%
1999 FY	-1.62 Million AUD	0.0%

Peer Operating Expenses Comparison of PolyNovo Limited

Name	Operating Expenses	Operating Expenses Difference
4DMedical Limited	31.48 Million AUD	-10.921%
Adherium Limited	267.7 Thousand AUD	-12945.054%
Aroa Biosurgery Limited	66.09 Million AUD	47.168%
Atomo Diagnostics Limited	1.6 Million AUD	-2074.467%
Anteris Technologies Ltd	69.14 Million AUD	49.498%
Control Bionics Limited	9.82 Million AUD	-255.407%
CardieX Limited	16.64 Million AUD	-109.755%
Compumedics Limited	26.88 Million AUD	-29.918%
Cochlear Limited	1.17 Billion AUD	97.027%
CleanSpace Holdings Limited	11.35 Million AUD	-207.43%
Cyclopharm Limited	13.38 Million AUD	-160.985%
EMVision Medical Devices Ltd	12.83 Million AUD	-172.114%
Nova Eye Medical Limited	23.99 Million AUD	-45.569%
HeraMED Limited	6.78 Million AUD	-414.849%
Imricor Medical Systems, Inc.	-1.11 Million AUD	3229.663%
ImpediMed Limited	28.04 Million AUD	-24.539%
InhaleRx Limited	2.59 Million AUD	-1248.062%
LBT Innovations Limited	1.1 Million AUD	-3054.652%
Micro-X Limited	18.76 Million AUD	-86.112%
Neurotech International Limited	8.75 Million AUD	-298.913%
OncoSil Medical Limited	12.03 Million AUD	-190.054%
Respiri Limited	8.03 Million AUD	-334.631%
SomnoMed Limited	58.97 Million AUD	40.783%
Universal Biosensors, Inc.	20 Million AUD	-74.608%
Uscom Limited	5.52 Million AUD	-532.64%
Visioneering Technologies, Inc.	9.63 Million AUD	-262.501%

Global Stocks Search

PolyNovo Limited (PNV.AX)

Operating Expenses Summary of PolyNovo Limited

Annual Operating Expenses Chart of PolyNovo Limited (2024 - 1999)

Historical Annual Operating Expenses of PolyNovo Limited (2024 - 1999)

Peer Operating Expenses Comparison of PolyNovo Limited